Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Ursodeoxycholic Acid

Ursodeoxycholic Acid: An In-depth Guide to Its Uses, Mechanism, Benefits, and Side Effects

Ursodeoxycholic acid (UDCA), also known as ursodiol, is a naturally occurring bile acid that has garnered significant attention in the medical field due to its various therapeutic properties. It is most commonly used to treat liver diseases, particularly those related to the biliary system, such as primary biliary cirrhosis (PBC) and gallstones. UDCA has a range of uses due to its ability to alter bile composition, improve liver function, and exert protective effects on liver cells.

What is Ursodeoxycholic Acid?

Ursodeoxycholic acid (UDCA) is a hydrophilic bile acid that is naturally found in small quantities in human bile. It is a secondary bile acid that is synthesized by bacteria in the intestines from cholic acid, which is one of the primary bile acids produced in the liver. UDCA plays a crucial role in the digestive system, helping emulsify fats and facilitating their absorption in the small intestine.

As a therapeutic agent, UDCA is a semisynthetic bile acid that is derived from chenodeoxycholic acid (CDCA), another naturally occurring bile acid. UDCA has been found to have unique properties that distinguish it from other bile acids, particularly in terms of its ability to reduce bile toxicity, improve liver function, and protect hepatocytes from damage.

The clinical applications of UDCA are broad, with its most common uses being in the management of liver diseases such as primary biliary cholangitis (PBC) and gallstone disease. UDCA is sold under various brand names, including Actigall and Ursodiol.

Mechanism of Action of Ursodeoxycholic Acid

Ursodeoxycholic acid exerts its therapeutic effects through several mechanisms that help improve liver function and reduce damage caused by disease. Its main mechanisms include:

1. Bile Acid Composition Alteration

UDCA alters the composition of bile by displacing toxic bile acids like chenodeoxycholic acid and cholic acid from the bile pool. This reduces the overall toxicity of bile and decreases the damaging effects that these acids can have on liver cells. By reducing the concentration of more harmful bile acids in the liver and bloodstream, UDCA can help protect hepatocytes and reduce inflammation in the liver.

2. Choleretic Effect

Ursodeoxycholic acid has a choleretic effect, meaning it increases the production of bile. This increase in bile production can help improve bile flow and reduce the build-up of toxic substances in the liver, which is particularly useful in diseases like primary biliary cirrhosis (PBC) where bile flow is impaired.

3. Liver Cell Protection

UDCA helps protect liver cells from damage by stabilizing cellular membranes and reducing the toxic effects of bile acids. This is particularly important in chronic liver diseases where bile acids can accumulate and cause liver cell injury. It also reduces oxidative stress and inflammation in the liver, which are common factors in liver disease progression.

4. Improvement of Cholestasis

Cholestasis is a condition where bile cannot flow properly from the liver to the duodenum. This can lead to a buildup of bile acids in the liver and bloodstream, causing liver damage. UDCA has been shown to improve bile flow in individuals with cholestasis, thereby preventing the harmful effects of bile acid accumulation.

5. Modulation of Immune Response

In diseases like primary biliary cholangitis (PBC), where there is an autoimmune component that targets the bile ducts, UDCA may help modulate the immune response by reducing inflammation and preventing further damage to bile ducts. This can lead to slower disease progression and improved liver function.

Clinical Uses of Ursodeoxycholic Acid

Ursodeoxycholic acid has a range of applications in clinical medicine, especially in the treatment of liver diseases and gallbladder conditions. Below are the key conditions for which UDCA is prescribed:

1. Primary Biliary Cirrhosis (PBC)

Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease characterized by the progressive destruction of bile ducts. As a result, bile accumulates in the liver, leading to liver damage, fibrosis, and eventually cirrhosis. UDCA is the first-line treatment for PBC, as it helps to improve liver function, reduce bile acid toxicity, and slow disease progression.

Effectiveness in PBC

  • UDCA has been shown to improve liver enzyme levels and reduce bilirubin levels in patients with PBC. It also improves serum alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) levels, which are markers of liver function.

  • Long-term treatment with UDCA has been associated with slower progression of liver damage, reduced risk of liver failure, and improved survival rates in PBC patients.

  • It may also improve symptoms of cholestasis such as pruritus (itching) and fatigue, which are common in patients with PBC.

2. Gallstones

UDCA is commonly used to treat gallstones, especially in patients who are not candidates for surgery or those who wish to avoid cholecystectomy (gallbladder removal). UDCA works by dissolving cholesterol gallstones and preventing the formation of new stones.

Effectiveness in Gallstone Disease

  • UDCA has been shown to be effective in dissolving cholesterol stones in the gallbladder. It works by decreasing the concentration of cholesterol in bile, preventing the formation of gallstones.

  • UDCA is most effective in patients with small, non-calcified cholesterol stones and functional gallbladders. Treatment typically lasts several months and requires careful monitoring.

3. Non-Alcoholic Fatty Liver Disease (NAFLD)

Although not officially approved for this condition, UDCA is sometimes used off-label in patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is a condition where fat accumulates in the liver without the presence of alcohol consumption, which can lead to inflammation and liver damage over time.

  • UDCA has shown potential benefits in improving liver function in some patients with NAFLD, though more research is needed to establish its definitive role in this condition.

4. Cystic Fibrosis-Related Liver Disease

In individuals with cystic fibrosis, liver disease is a common complication. Biliary cirrhosis is a frequent manifestation, and UDCA can be used to improve bile flow, reduce liver damage, and alleviate symptoms of cholestasis.

5. Other Cholestatic Liver Diseases

UDCA may also be used to treat other conditions involving cholestasis (impaired bile flow), such as sclerosing cholangitis, where it helps to improve liver function and protect the liver from further damage.

Dosage and Administration of Ursodeoxycholic Acid

The dosage of UDCA depends on the condition being treated and the patient’s overall health. UDCA is typically taken orally in the form of tablets or capsules, usually with food to enhance absorption. The dose is often adjusted based on the patient’s response and the severity of their condition.

General Dosing Guidelines:

  1. Primary Biliary Cirrhosis (PBC):

    • The typical dose is 13-15 mg/kg/day, divided into two or three doses.

  2. Gallstones:

    • The typical dose for dissolving gallstones is 8-10 mg/kg/day, divided into two doses.

  3. Non-Alcoholic Fatty Liver Disease (NAFLD):

    • Off-label dosing varies, but UDCA is usually given in doses ranging from 10-15 mg/kg/day.

  4. Cystic Fibrosis Liver Disease:

    • The recommended dose is 10-15 mg/kg/day, divided into two or three doses.

It is important to follow the prescribed dosage and schedule provided by a healthcare provider to ensure the medication’s effectiveness and minimize side effects.

Side Effects of Ursodeoxycholic Acid

While Ursodeoxycholic acid is generally well-tolerated, like all medications, it can cause side effects in some patients. The most common side effects include:

1. Gastrointestinal Symptoms

  • Diarrhea

  • Nausea

  • Abdominal discomfort

These side effects are usually mild and resolve with time or dose adjustments.

2. Allergic Reactions

In rare cases, patients may experience allergic reactions to UDCA, including:

  • Rashes

  • Itching

  • Swelling

If any allergic reactions occur, it is important to discontinue the medication and seek medical attention.

3. Liver Function Tests

In rare cases, liver enzymes such as AST and ALT may increase while taking UDCA. Regular monitoring of liver function is recommended during treatment, especially in patients with pre-existing liver conditions.

4. Other Rare Side Effects

  • Hair loss (alopecia) has been reported in some patients.

  • Fatigue or weakness may occur in rare instances.

  • Elevated cholesterol levels can occur in some individuals.

Precautions and Contraindications

Before starting Ursodeoxycholic acid, it is essential to inform the healthcare provider

about any pre-existing liver conditions, gallbladder disease, or other medical conditions. Special care should be taken in patients with renal dysfunction, severe liver impairment, or gallbladder dysfunction.

Contraindications:

  • Hypersensitivity to UDCA or any of its components.

  • Gallbladder non-function (in patients with severe gallbladder disease where gallbladder contraction is impaired).

Monitoring:

  • Regular monitoring of liver function tests (LFTs) is recommended, especially in the early stages of treatment.

Conclusion

Ursodeoxycholic acid (UDCA) is a critical medication for treating various liver diseases, particularly those related to bile duct obstruction, cholestasis, and gallstone disease. Its ability to modify bile composition, improve bile flow, and protect liver cells makes it an essential tool in hepatology.